The Ministry Of Health, By Force Of Court Order, Summons Companies Interested In Supplying, Via Direct Contracting, The Following Strategic Health Inputs: Human Immunoglobulin Concentration: 200Mg/Ml, Pharmaceutical Form: Injectable Solution - 10 Ml; Selumetinib Concentration: 10Mg; Selumetinib Concentration: 25Mg; Enzalutamide Concentration: 40Mg; Ruxolitinib Concentration: 5Mg; Cetuximab Concentration: 5Mg/Ml, Pharmaceutical Form: Injectable Solution - 100 Ml; Cetuximab Concentration: 5Mg/Ml, Pharmaceutical Form: Injectable Solution - 20 Ml; Medicinal Extract Active Ingredient: Cannabidiol Oil, Concentration: 50Mg/Ml, Pharmaceutical Form: Oral Solution Canabidiol Pratidonaduzzi 50 Mg/Ml, 30 Ml; Cannabidiol Concentration: 200Mg/Ml, Pharmaceutical Form: Oral Solution - Drops Canabidiol Prati-Donaduzzi 200 Mg/Ml, 30 Ml And Lacosamide Concentration: 100Mg.

MINISTERIO DA SAUDE - Secretaria Executiva - Subsecretaria de Assuntos Administrativos - Departamento de Logistica Brazil has Released a tender for The Ministry Of Health, By Force Of Court Order, Summons Companies Interested In Supplying, Via Direct Contracting, The Following Strategic Health Inputs: Human Immunoglobulin Concentration: 200Mg/Ml, Pharmaceutical Form: Injectable Solution - 10 Ml; Selumetinib Concentration: 10Mg; Selumetinib Concentration: 25Mg; Enzalutamide Concentration: 40Mg; Ruxolitinib Concentration: 5Mg; Cetuximab Concentration: 5Mg/Ml, Pharmaceutical Form: Injectable Solution - 100 Ml; Cetuximab Concentration: 5Mg/Ml, Pharmaceutical Form: Injectable Solution - 20 Ml; Medicinal Extract Active Ingredient: Cannabidiol Oil, Concentration: 50Mg/Ml, Pharmaceutical Form: Oral Solution Canabidiol Pratidonaduzzi 50 Mg/Ml, 30 Ml; Cannabidiol Concentration: 200Mg/Ml, Pharmaceutical Form: Oral Solution - Drops Canabidiol Prati-Donaduzzi 200 Mg/Ml, 30 Ml And Lacosamide Concentration: 100Mg. in Healthcare and Medicine. The tender was released on Jan 10, 2025.

Country - Brazil

Summary - The Ministry Of Health, By Force Of Court Order, Summons Companies Interested In Supplying, Via Direct Contracting, The Following Strategic Health Inputs: Human Immunoglobulin Concentration: 200Mg/Ml, Pharmaceutical Form: Injectable Solution - 10 Ml; Selumetinib Concentration: 10Mg; Selumetinib Concentration: 25Mg; Enzalutamide Concentration: 40Mg; Ruxolitinib Concentration: 5Mg; Cetuximab Concentration: 5Mg/Ml, Pharmaceutical Form: Injectable Solution - 100 Ml; Cetuximab Concentration: 5Mg/Ml, Pharmaceutical Form: Injectable Solution - 20 Ml; Medicinal Extract Active Ingredient: Cannabidiol Oil, Concentration: 50Mg/Ml, Pharmaceutical Form: Oral Solution Canabidiol Pratidonaduzzi 50 Mg/Ml, 30 Ml; Cannabidiol Concentration: 200Mg/Ml, Pharmaceutical Form: Oral Solution - Drops Canabidiol Prati-Donaduzzi 200 Mg/Ml, 30 Ml And Lacosamide Concentration: 100Mg.

Deadline - Jan 17, 2025

GT reference number - 101264223

Product classification - Medical equipments, pharmaceuticals and personal care products